NDC 64365-504 - Targretin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64365-504
- Package NDCs from labels
- 64365-504-01
- Manufacturer
- Ligand Pharmaceuticals Inc.
- Effective date
- 2006-03-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Targretin ® (bexarotene) gel 1% | Ligand Pharmaceuticals Inc. | 2006-03-28 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64365-504-01 | Targretin | 60 g in 1 TUBE | GEL | 60 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| bexarotene | ACTIVE INGREDIENT | A61RXM4375 | TARGRETIN (BEXAROTENE) GEL [LIGAND PHARMACEUTICALS INC.] | 1 | |
| bexarotene | ACTIVE MOIETY | A61RXM4375 | TARGRETIN (BEXAROTENE) GEL [LIGAND PHARMACEUTICALS INC.] | 1 | |
| butylated hydroxytoluene | INACTIVE INGREDIENT | TARGRETIN (BEXAROTENE) GEL [LIGAND PHARMACEUTICALS INC.] | 1 | ||
| dehydrated alcohol | INACTIVE INGREDIENT | TARGRETIN (BEXAROTENE) GEL [LIGAND PHARMACEUTICALS INC.] | 1 | ||
| hydroxypropyl cellulose | INACTIVE INGREDIENT | TARGRETIN (BEXAROTENE) GEL [LIGAND PHARMACEUTICALS INC.] | 1 | ||
| polyethylene glycol 400 | INACTIVE INGREDIENT | TARGRETIN (BEXAROTENE) GEL [LIGAND PHARMACEUTICALS INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bexarotene | BEXAROTENE | Amneal Pharmaceuticals NY LLC | 2c21f361-e3d1-45a5-a6e7-df8164e3f90d | 2023-12-29 | Adverse reactions | 308724 |
| Targretin | BEXAROTENE | Bausch Health US, LLC | d35b4697-3f3b-4aa1-b5d9-153993e83811 | 2020-02-03 | Adverse reactions | 308724 991233 |
| E415C4C8-3144-4172-94A0-F4F3243130AE | E415C4C8-3144-4172-94A0-F4F3243130AE | 2006-03-28 | Adverse reactions | E415C4C8-3144-4172-94A0-F4F3243130AE E415C4C8-3144-4172-94A0-F4F3243130AE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.